3.589USD+10.24%Mkt Cap: 32.69M USDP/E: —Last update: 2026-06-01
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational prod…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap32.69M USD
Enterprise Value16.28M USD
Revenue (TTM)170.00K USD
Gross Profit170.00K USD
Net Income (TTM)-16.59M USD
Revenue/Share0.0190 USD
Last Price3.589 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees21
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.80
PEG118.40
EV/EBITDA-0.95
EV/Revenue95.78
P/S174.09
P/B2.71
EPS (TTM)-1.86
EPS (Forward)-1.16
52W Range
1.81055% of range5.070
52W High5.070 USD
52W Low1.810 USD
Profitability
Gross Margin100.00%
Oper. Margin-10178.82%
EBITDA Margin0.00%
Profit Margin-9756.47%
ROE-111.65%
ROA-93.47%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.95M USD
CapEx (TTM)28.00K USD
FCF Margin-4740.59%
FCF Yield-24.65%
Net Debt-13.06M USD
Net Debt/EBITDA0.76
Balance Sheet
Debt/Equity0.00
Current Ratio4.23
Quick Ratio3.94
Book Value/Sh1.200 USD
Cash/Share1.434 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateSep 15, 2022
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)4.000 USD
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.9.11M
Float7.19M
Insiders20.89%
Institutions11.43%
Short Interest
Short Ratio1.3d
Short % Float1.24%
Short % Out.1.03%
Shares Short93.49K
Short (prev mo.)51.64K
Technical
SMA 503.898 (-7.9%)
SMA 2003.111 (+15.4%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)74.85K
Avg Vol (10d)31.06K
Technical Indicators
RSI (14)44.2
MACD-0.1280
MACD Signal-0.1889
MACD Hist.+0.0609
BB Upper3.364 USD
BB Middle3.211 USD
BB Lower3.059 USD
BB Width9.49%
ATR (14)0.1482 USD
Vol Ratio (20d)4.33x